Radhwan Al-Zidan

Mr. Radhwan Al-Zidan

University of Mosul, College of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2021 in Bioengineering
Verified
Journal Article
Open access
PDF file
HAHASAN ALDEWACHI
HASAN ALDEWACHI
Radhwan Al-ZidanRadhwan Al-Zidan
Radhwan Al-Zidan
MCMatthew T. Conner
Matthew T. Conner
Mootaz SalmanMootaz Salman
Mootaz Salman
Neurodegenerative diseases (NDDs) are incurable and debilitating conditions that result in progressive degeneration and/or death of nerve cells in the central nervous system (CNS). Identification of viable therapeutic targets and new treatments for CNS disorders and in particular, for NDDs is a major challenge in the field of drug discovery. These difficulties can be attributed to the diversity of cells involved, extreme complexity of the neural circuits, the limited capacity for tissue regeneration, and our incomplete understanding of the underlying pathological processes. Drug discovery is a complex and multidisciplinary process. The screening attrition rate in current drug discovery protocols mean that only one viable drug may arise from millions of screened compounds resulting in the need to improve discovery technologies and protocols to address the multiple causes of attrition. This has identified the need to screen larger libraries where the use of efficient high-throughput screening (HTS) becomes key in the discovery process. HTS can investigate hundreds of thousands of compounds per day. However, if fewer compounds could be screened without compromising the probability of success, the cost and time would be largely reduced. To that end, recent advances in computer-aided design, in silico libraries, and molecular docking software combined with the upscaling of cell-based platforms have evolved to improve screening efficiency with higher predictability and clinical applicability. We review, here, the increasing role of HTS in contemporary drug discovery processes, in particular for NDDs, and evaluate the criteria underlying its successful application. We also discuss the requirement of HTS for novel NDD therapies and examine the major current challenges in validating new drug targets and developing new treatments for NDDs.

9 October 2025 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
SDSagar R. Dubey
Sagar R. Dubey
CTCynthia Turnbull
Cynthia Turnbull
APAbhimanu Pandey
Abhimanu Pandey
AZAnyang Zhao
Anyang Zhao
MKMelan Kurera
Melan Kurera
SMSi Ming Man
Si Ming Man
The inflammasome is an inflammatory signaling protein complex comprising a sensor protein, the adaptor protein ASC, and the cysteine protease caspase-1. Inflammasome sensor proteins are activated by microbial molecular patterns, endogenous self-derived damage signals, or exogenous environmental danger signals. Multiple inflammasomes that differ in their mechanisms of action and structural composition have been identified. The best characterized are the canonical NLRP1, NLRP3, NAIP-NLRC4, AIM2, and Pyrin inflammasomes and the noncanonical inflammasomes activated by caspase-4, caspase-5 or caspase-11. The lesser known inflammasomes are the NLRP6, NLRP7, NLRP9, NLRP10, NLRP12, CARD8, and MxA inflammasomes. Following inflammasome assembly, caspase-1 promotes the secretion of the proinflammatory cytokines IL-1β and IL-18, and pyroptosis is mediated by the membrane-disrupting proteins gasdermin D and ninjurin-1. These functional activities control innate and adaptive immune responses and the initiation, development, and progression of autoinflammation, cancer, infectious diseases, and neurodegenerative diseases. Understanding how inflammasomes respond to pathogens and sterile signals has refined our view of innate immunity and offered new therapeutic targets. In this review, we present a comprehensive overview of inflammasomes with an emphasis on the mechanistic principles that govern inflammasome formation. We also discuss the contributions of inflammasome activation to health and disease.

3 April 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
Omeed DarweeshOmeed Darweesh
Omeed Darweesh
Amanj KurdiAmanj Kurdi
Amanj Kurdi
MMMarwan M. Merkhan
Marwan M. Merkhan
Hemn Omer AhmedHemn Omer Ahmed
Hemn Omer Ahmed
SISalih Ibrahem
Salih Ibrahem
BGBrian Godman
Brian Godman
Background: Antibiotic misuse is a major global health issue, particularly in low- and middle-income countries (LMICs), where inappropriate use contributes to antimicrobial resistance (AMR). Inappropriate antibiotic use is exacerbated in LMICs by pressure from parents on physicians and pharmacists to prescribe and dispense antibiotics for their children, often for viral infections. There is currently limited knowledge of key issues in Iraq to improve future antibiotic use. Consequently, we explored knowledge, attitudes, and practices (KAPs) of Iraqi parents regarding antibiotic use in their children to provide future direction. Methods: A cross-sectional survey was conducted between November 2023 and September 2024 among 1878 parents in four districts of Iraq. A structured questionnaire assessed parents’ KAPs towards antibiotic-related uses and practices. Data were analyzed using descriptive statistics and Chi-square tests to examine the associations between demographic variables and KAP indicators. Results: Among the participants, 83% were aware that antibiotics are ineffective for viral infections, and 75% recognized potential side effects from antibiotics. Despite this knowledge, 63% of parents admitted to administering antibiotics to their children without a prescription, with 42% discontinuing treatment once symptoms improved. Factors including cost, dosage, and taste influenced antibiotic selection. Parents with higher education and income levels were more likely to engage in self-medication. Pharmacists were the primary source of antibiotic information for 52% of respondents. Conclusions: Despite adequate knowledge, inappropriate practices such as self-medication and discontinuing treatment early were prevalent. Targeted educational campaigns, particularly among parents with higher education levels and incomes, are necessary to mitigate AMR in Iraq.

22 April 2021 in Current Pharmacology Reports
Verified
Journal Article
Closed access
PDF file
MAMyasar Alkotaji
Myasar Alkotaji
Radhwan Al-ZidanRadhwan Al-Zidan
Radhwan Al-Zidan

5 August 2021 in Current Pharmacology Reports
Verified
Journal Article
Closed access
PDF file
ODOmeed Darweesh
Omeed Darweesh
GAGhayth M. Abdulrazzaq
Ghayth M. Abdulrazzaq
Radhwan Al-ZidanRadhwan Al-Zidan
Radhwan Al-Zidan
PBPshtiwan Bebane
Pshtiwan Bebane
MMMarwan Merkhan
Marwan Merkhan
NANohad AlOmari
Nohad AlOmari

15 November 2020 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
SMSaad M. Majeed
Saad M. Majeed
MAMohammed K. Al-Shaheen
Mohammed K. Al-Shaheen
Radhwan Al-ZidanRadhwan Al-Zidan
Radhwan Al-Zidan
SMSameer M. Mahmood
Sameer M. Mahmood
Multiparticulate drug delivery systems are mainly oral dosage form, consist of small discrete units that exhibit different characteristics especially in release pattern and drug bioavailability. These systems are represented by granules, pellets, microspheres, microcapsules, and minitablets. Pellets offer high flexibility in the design, formulation, and development of oral dosage forms such as sachet, suspension, capsule, and tablet. Multiparticulate tablets manufactured by compaction of multiple unite pellets is one of the latest and, yet, challenging technologies. Multiparticulate tablets combine the benefits of both a tablet and a pellet-filled capsule in one dosage form but their manufacturing experience many difficulties. The oral multiparticulate products consist of polymer-coated subunits or pellets, which are embedded in an inert excipients’ matrix, formulated to overcome the difficulty in administering capsules and improve the physicochemical stability of suspension and offer predictable release and uniform distribution in the gastro-intestinal tract compared to the plain tablet. This review discusses the advantages and drawbacks of MUPS, the properties of an ideal MUPS, various pharmaceutical applications of MUPS, the challenges and key variables that to be considered in the tableting process for successful production of MUPS Keywords: MUPS®, Pellets, Multiparticulate tablets.